Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Pharmaceutical Technology
JULY 4, 2022
Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Pharmstandard (Moscow, Russia) and Pharmasyntez (Irkutsk Oblast, Russia) own five facilities each in Russia, the most of any pharma company.
305 
Let's personalize your content